ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TEVA Teva Pharmaceutical Industries Ltd

13.32
0.00 (0.00%)
Pre Market
Last Updated: 07:19:08
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Teva Pharmaceutical Industries Ltd TEVA NYSE Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 13.32 07:19:08
Open Price Low Price High Price Close Price Prev Close
13.32
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
3/07/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
3/05/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202406:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202406:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202407:00BWTeva and Jiangsu Nhwa Forge Strategic Partnership to Promote..
2/23/202420:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
2/23/202420:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
2/20/202408:30BWTeva Presents New Data Supporting Safety, Tolerability and..
2/13/202409:05IHMARKETNEWSHotter-Than-Expected Inflation Data Likely To Weigh On Wall..
2/12/202417:03IHMARKETNEWSDow Reaches New Record Closing High But Nasdaq, S&P 500 Give..
2/12/202409:13IHMARKETNEWSTeva Pharmaceutical, Urban Outfitters Upgraded
2/01/202407:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202407:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202407:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202407:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202407:00EDGAR2Form 8-K - Current report
1/31/202407:00BWTeva Reports Growth in Fourth Quarter and Full Year 2023
1/31/202406:00BWTeva Announces Intention to Divest API Business as Part of..
1/02/202416:30BWTeva to Host Conference Call to Discuss Fourth Quarter and..
1/02/202408:50DJNCorcept Therapeutics Shares Slide Premarket on Loss in Teva..
12/28/202316:30BWTeva to Present at the 42nd Annual J.P. Morgan Healthcare..
12/14/202308:30BWTeva and Biolojic Design Announce Exclusive License..
12/06/202311:19BWNeue Post-Hoc-Analyse von Phase-3-Daten zeigt, dass AJOVY®..
12/06/202309:24BWUne nouvelle analyse post hoc des données de phase 3 montre..
12/06/202302:00BWNew Post Hoc Phase 3 Data Analysis Shows AJOVY®..
11/30/202309:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
11/30/202308:30BWTeva Completes Closing of Exclusive Collaboration Deal to..
11/22/202307:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202307:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/20/202316:30BWTeva to Present at the 6th Annual Evercore ISI HealthCONx..

Your Recent History

Delayed Upgrade Clock